Galapagos NV | GLPG Annual Report & Investor Relations Data
ISIN
BE0003818359
Ticker
GLPG
Sector
Industry
Country
Belgium
Year Founded
1999
ISIN
BE0003818359
Ticker
GLPG
Sector
Industry
Country
Belgium
Year Founded
1999
We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.
Worldwide
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
Limited spots available. Join now!
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 03.07.2024 | Huston Thad | Board | Buy | EUR 0.00 |
| 17.05.2024 | Stoffels IMC | Board | Buy | EUR 0.00 |
| 01.05.2024 | Stoffels IMC | Board | Other | EUR 1,428,334.05 |
| 01.05.2024 | Missotten Annelies | Board | Other | EUR 373,990.65 |
| 01.05.2024 | Cnossen Valeria | Board | Other | EUR 368,885.55 |
| 01.05.2024 | Huston Thad | Board | Other | EUR 354,439.80 |
| 30.04.2024 | GILEAD THERAPEUTICS A1 UNLIMITED COMPANY | Close relation | Other | EUR 0.00 |
| 21.12.2023 | Guenter Peter | Board | Buy | EUR 23,069.75 |
| 21.12.2023 | Baker Daniel George | Board | Buy | EUR 22,736.24 |
| 21.12.2023 | Schaffert Susanne Antonie | Board | Buy | EUR 12,896.14 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
BE0003818359
549300QKJ78IY0IOV655
BEL20
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …
AB
Sector
Health Care
Country
France
ISIN
FR0010557264
Founded
2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …
ALACT
Sector
Health Care
Country
France
ISIN
FR0014005OJ5
Founded
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …
ACTI
Sector
Health Care
Country
Sweden
ISIN
SE0001137985
Founded
1998
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …